Roxana Dronca

Author PubWeight™ 8.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet 2014 8.63